Development and validation of relative activity evaluation method for SARS-CoV-2 neutralizing antibody based on Design of Experiment
Objective To develop and validate an evaluation method based on Design of Experiment(DOE)for the relative activity of SARS-CoV-2 neutralizing antibody,so as to provide a reliable detection method for the development and quality evaluation of SARS-CoV-2 neutralizing antibody.Methods A method for evaluating the relative activity of SARS-CoV-2 neutralizing antibody was developed by using SARS-CoV-2 variant pseudovirus.The cell density[(3-5)× 105 cells/mL],pseudovirus titer(3 750-6 250 TCID50/mL),neutralization time of antibody to pseudovirus(0.5-1.5 h),and interaction time of antibody-pseudovirus complex and cells(48-96 h)were optimized by DOE.The optimized method was verified for the specificity,linear range,accuracy and precision,and used to detect the relative activity of two batches of SARS-CoV-2 neutralizing antibodies.Results The optimum cell density was 4 × 105 cells/mL,the titer of pseudovirus was 6 250 TCID50/mL,the neutralization time of antibody to pseudovirus was 1.5 h,and the interaction time of antibody-pseudovirus complex and cells was 96 h.Only SARS-CoV-2 neutralizing antibody showed a typical dose-response curve,while anti-VEGF monoclonal antibody and sample diluent did not show a dose-response curve.The theoretical titer of SARS-CoV-2 neutralizing antibody in the range of 50%-200%showed a good linear relationship with the detection value,and the linear equation was y=1.034 2x-0.013,r=0.958 8.The relative bias of the mean values of the three test results of the samples at the relative titer levels of 50%,71%,100%,141%and 200%ranged from 6.2%to 7.3%,and the geometric coefficient of variation(GCV)ranged from 3.2%to 16.9%.The relative activity of the two batches of SARS-CoV-2 neutralizing antibodies was 91%and 118%respectively.Conclusion The developed method has good specificity,accuracy and precision,and can be used for the detection of the relative activity of SARS-CoV-2 neutralizing antibody.
Design of Experiment(DOE)SARS-CoV-2Variant strainPseudovirusNeutralizing antibodyRelative activity